# Enlivex (ENLV) — Overview

ENLV · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/enlv

## Price

Last close $0.22 on Oct 15, 2026. 52-week range $0.22 – $18.15.

## Company profile

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $0.00 |
| Revenue (quarter) | $0.00 |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $0.00 |
| Gross margin | 0.00% |
| Net income (trailing twelve months) | $0.00 |
| Net income (quarter) | $1.9B |
| Net income growth (year over year) | 101364.13% |
| Net margin | 0.00% |
| Return on equity | 162.86% |
| EPS (trailing twelve months) | $529.10 |
| Book value per share | $242.58 |
| P/E (trailing twelve months) | 0.0 |
| Price to book | 0.0 |
| Debt to assets | 20.44% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### What is ENLV's P/E ratio?

Enlivex trades at 0.0 times trailing twelve-month earnings, on an EPS of $529.10.

### How do I buy stock in Enlivex (ENLV)?

ENLV trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).